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Background: Volumetric capnography reﬂecting the course of CO2-exhalation is used to assess ventilation inhomogeneity. Calculation of the
slope of expiratory phase 3 and the capnographic index (KPIv) from expirograms allows quantiﬁcation of extent and severity of small airway
impairment. However, technical limitations have hampered more widespread use of this technique. Using expiratory molar mass–volume-curves
sampled with a handheld ultrasonic ﬂow sensor during tidal breathing is a novel approach to extract similar information from expirograms in a
simpler manner possibly qualifying as a screening tool for clinical routine.
The aim of the present study was to evaluate calculation of the KPIv based on molar mass–volume-curves sampled with an ultrasonic ﬂow
sensor in patients with CF and controls by assessing feasibility, reproducibility and comparability with the Lung Clearance Index (LCI) derived
from multiple breath washout (MBW) used as the reference method.
Methods: Measurements were performed in patients with CF and healthy controls during a single test occasion using the EasyOne Pro, MBW
Module (ndd Medical Technologies, Switzerland).
Results: Capnography and MBW were performed in 87/96 patients with CF and 38/42 controls, with a success rate of 90.6% for capnography.
Mean age (range) was 12.1 (4–25) years. Mean (SD) KPIv was 6.94 (3.08) in CF and 5.10 (2.06) in controls (p=0.001). Mean LCI (SD) was 8.0
(1.4) in CF and 6.2 (0.4) in controls (p=b0.001) and correlated signiﬁcantly with the KPIv (p=b0.001).
Conclusion: Calculation of the KPIv based on molar mass–volume-curves is feasible. KPIv is signiﬁcantly different between patients with CF and
controls and correlates with the LCI. However, individual data revealed a relevant overlap between patients and controls requiring further
evaluation, before this method can be recommended for clinical use.
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http://dx.doi.org/10.1016/j.jcf.2012.08.011progression of bronchiectasis and pulmonary fibrosis is one of
the most important tasks in the management of CF patients.
Structural damage may be present without any pulmonary
symptoms and in the presence of normal spirometry [1,2].
However spirometry is not sensitive in detecting peripheral
airway obstruction in early stages of CF lung disease, as it only
reflects changes down to the 8th bronchus generation. Nevertheless
the forced expired volume in 1 s (FEV1), is commonly used for
monitoring and as outcome parameter for clinical and research
purposes [3,4].by Elsevier B.V. All rights reserved.
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overall ventilation inhomogeneity (VI) that is sensitive for
identifying airway obstruction at an earlier and more peripheral
stage of CF lung disease [5–8]. The Lung Clearance Index
(LCI=cumulative expired volume / functional residual capacity)
derived from MBW correlates in children and adolescents with
structural lung damage obtained using computed tomography
[9–11].
However, MBW test duration is long and the use of an inert
tracer gas makes it difficult to use MBW outside a laboratory
setting. In addition availability of licensed tracer gases is limited.
A simple yet sensitive screening test is needed aiming to
detect onset and progression of CF lung disease and to assess
the response to therapeutic interventions. Capnography has
been discussed as a quick and simple tidal breathing test
that indicates a delayed CO2 exhalation in the presence of
peripheral airway obstruction and may thus be sensitive for
monitoring CF lung disease. Several approaches have previ-
ously been introduced in order to extract information on
peripheral airway impairment from CO2-expirograms [12–16].
Plotting exhaled carbon dioxide concentration against expired
volume allows dividing the expiration in three separate phases:
phase 1 reflects dead space respiration; phase 2 reflects exhaled
CO2 from the conducting airways and phase 3 from the acinar
region. As poorly ventilated lung areas contribute more to the
latter part of the expirogram than unimpaired lung units, phase
3 becomes steeper with increasing peripheral airway obstruc-
tion and ventilation inhomogeneity. Calculation of the slope
of phase 2 (S2) and slope of phase 3 (S3) and subsequent
calculation of the capnographic index (KPIv= [S3/S2]∗100)
have been introduced to quantify the degree of small airway
impairment [17]. Conventionally, a CO2-analyser plus a flow
meter is necessary to perform capnography. Although promising,
hardware and software related limitations, such as slow responseM
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Fig. 1. Molar mass–volume-curves derived from capnography in a patient wtime of available CO2-analysers, lack of evaluated procedures for
time delay correction of side stream signals and time consuming
calibration procedures, have hindered widespread application of
capnography.
Capnography based on expiratorymolar mass–volume-curves
derived from an ultrasonic flow sensor during tidal breathing
is a novel approach to extract information similar to that
obtained using conventional capnography in a simpler manner
that possibly qualifies as a screening tool for clinical routine
(Fig. 1) [18].
We hypothesized that capnography based on expiratory
molar mass–volume-curves is sensitive for detecting peripheral
airway changes in patients with CF and that parameters derived
from this test correlate with the LCI as the reference parameter.
The aims of the present study were:1. to compare capnography using the ultrasonic technology in
patients with CF and controls
2. to assess short term reproducibility of KPIv in controls and
3. to correlate KPIv and LCI in patients with CF and healthy
controls.2. Methods
2.1. Setting and participants
This prospective study was mainly carried out between 2006
and 2008 at the Department of Paediatric Pneumology and
Neonatology, Medical School Hanover, Germany and the CF
Centre of the Medical University Innsbruck, Austria.
The equipment used for the study was the EasyOne Pro,
MBWModule (nddMedical Technologies, Zurich, Switzerland).
Measurements were performed by one observer with the GermanControl: 6.6 years, tidal volume 12.1
mL/kg/bodyweight, LCI= 6.0
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of the study.
All patients with CF attending the centre for their annual
check-up were eligible for the study. The routine diagnostic
workup for CF patients was subsequently performed as usual.
Healthy children and adolescents without a history of lower
respiratory tract diseases and absence of a current upper air way
infection were recruited as control group. Children with atopy
but without any pulmonary symptoms were allowed to take part
in the study.
The study was approved by the local ethics committees.
Parental informed written consent and patient assent were
obtained prior to the measurements.
2.2. Protocol
The study was conducted during a single test occasion. For
capnography each participant performed 1–2 min of tidal
breathing with the EasyOne Pro, MBW Module prior to any
other lung function test. Subsequent MBW was performed in
triplicate.
All measurements were performed in a sitting position,
breathing quietly through a mouth piece, wearing a nose clip
while watching a video.
Additional information such as age, weight, standing height,
heart rate and O2-saturation were documented in the protocol
for each subject.
The healthy volunteers at the Hannover study site (n=21)
were asked to repeat capnography and MBW after an interval
of 1 h for assessment of short term reproducibility.
2.3. Equipment
The ultrasonic technology of the side stream ultrasonic flow
sensor was described previously [19–21]. Briefly the ultrasonic
flow sensor (Spiroson®, ndd Medical Technologies, Zurich,
Switzerland) contains two ultrasonic transducers which are
mounted on opposite sides. Both transducers emit ultrasonic
pulses travelling through the streaming inspired and expired air.
The moving air causes an increase in the upstream and a decrease
in the downstream transit time of the ultrasound. The change
in transit times is related to the gas velocity of the air flow. In
addition, molar mass (MM) of the inspired and expired air can be
computed breath by breath from the transit times. MM values are
directly proportional to the density of the gas mixture. Measuring
MM for assessing gas concentrations has previously been
validated versus mass spectrometry. The ultrasonic flow sensor
sampled with 200 Hz, has a fast response time and does not
require any calibration procedures before use [21].
The EasyOne Pro, MBWModule (nddMedical Technologies,
Zurich, Switzerland) used for the present study is suitable for
both, capnography andMBWmeasurements. The device consists
of a main stream ultrasonic transducer for simultaneous flow and
main stream molar mass (MMms) sampling and a side stream
ultrasonic transducer for measuring side stream molar mass
(MMss) of the respired gas independently of temperature and
humidity. BTPS correction and a delay correction synchronisingmain stream flow and MMss are to be performed prior to any
analysis. Delay correction is based on the MMms signal that is
used as the reference signal for this procedure. Off-line analysis is
easily performed using a batch evaluation option that is part of
the commercial software WBreath© used for data acquisition,
storage and analysis. The total apparatus dead space of the device
is 38 mL. Requiring a total apparatus dead space of less than
2 mL kg/body weight, the device is applicable from age 4. The
equipment is used with a disposable filter tube (Spirette®) that
has proved hygienic safety [22].
A gas bias flow system provides valve-controlled tracer gas
delivery for MBW and is removed and inactivated during
capnography. For MBW, the inert tracer gas mixture contains
4% sulphur hexafluoride (SF6), 21% oxygen and balanced
nitrogen (Linde AG, Germany).
2.4. Volumetric capnography
Volumetric capnography is a non-invasive tidal breathing
test that takes 1–2 min time and is used without any additional
tracer gas.
Subjects breathed quietly through the mouthpiece of the
EasyOne Pro, MBW Module while the bias flow system is
inactivated and removed from the ultrasonic sensor. Flow,
volume and MMss of the respired air are sampled for the entire
duration of the test while the participant breathes room air.
Subjects were encouraged to breathe regularly.
Expiratory molar mass–volume-curves were constructed
off-line from all regular tidal breaths with a tidal volume
N8 mL/kg/body weight, within +/−20% of the median breath
volume and a ratio of b0.5 for tPEF/Texpiration. At least 10
breaths meeting these criteria were required to include the test
into final analysis.
Acceptable breaths were then averaged to produce a single
molar mass–volume-curve for this test (Fig. 1).
The steepness of S2 [g/mol/L] and S3 [g/mol/L] describing
the course of CO2 exhalation is calculated from this averaged
CO2 molar mass–volume curve.
For assessing S2, an integration line that covers a volume
interval of +/−20 mL is used to calculate the slope of each data
point of phase 2 of the molar mass–volume-curve in order to
detect its maximal slope. The interval for assessing the steepness
of S3 is defined between that point of the molar mass–volume
curve where the slope falls below 15% of S2 and the last data
point of the curve.
The capnographic index (KPIv) is calculated as the ratio of
S3 [g/mol/L] and S2 [g/mol/L]:
KPIv ¼ S3=S2ð Þ100:
2.5. MBW
MBWwas performed as described previously [5–8] using the
EasyOne Pro,MBWModule. All subjects aimed to perform three
technically acceptable MBW tests during one test occasion but at
least two with a functional residual capacity (FRC) differing by
less than 10% between these two measurements.
Table 1
Lung function parameters reported as mean of the group (SD) derived from
capnography and multiple breath washout in CF and controls. Slope 2 of the
CO2-expirogram = S2, slope 3 of the CO2-expirogram = S3, capnographic index =
KPIv ([S3/S2]∗100), mean tidal volume per kilogram body weight = TV/kg, and
Lung Clearance Index = LCI (cumulative expired volume/functional residual
capacity).
CF Controls p-value
S2 [g/mol/L] 32.8 (8.6) 34.4 (8.8) 0.324
S3 [g/mol/L] 2.2 (1.0) 1.8 (1.0) b0.027
KPIv 7.0 (3.1) 5.1 (2.1) 0.001
TV/kg [mL] 12.3 (3.1) 13.3 (3.7) 0.107
LCI 8.0 (1.4) 6.2 (0.4) b0.001
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Fig. 2. Individual capnographic index (KPIv=[S3/S2]∗100) versus age (years)
in n=87 CF patients (●) and n=38 controls (○).
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The upper limit of normal (mean+2SD) for the LCI measured
with the EasyOne Pro, MBW Module is ≤7 [23].
2.6. Statistics
Demographic data such as age, weight and height, and
group data of S2, S3, KPIv and LCI are reported as mean with
standard deviation (SD) or range for both groups. Normal
distribution of data was assessed using the Levene-test. A
Pearson correlation analysis was used to investigate the
correlation between LCI and KPIv. The upper limit of normal
was defined as the mean KPIv of the control group plus two
interindividual SD.
For investigating the short term reproducibility of the KPIv
agreement between the 1st and the 2nd tests was assessed using
the method described by Bland and Altman. For this method
the mean KPIv of the two tests is plotted against the difference
between the two for each subject. Limits of agreement are defined
as the mean difference of the two tests for the group +/− two SD
above and below this mean difference [24].
Paired t-tests were used to assess differences of KPIv between
the tests. p=b0.05 was defined to be statistically significant.
The statistical package used was SPSS version 19.0 for
Windows.
3. Results
96 children and adolescents with CF and 42 healthy controls
participated in the study. Capnography and MBW were readily
performed and well tolerated by all participants. 87/96 (90.6%)
patients with CF and 38/42 (90.5%) controls produced capno-
graphic expirograms meeting the defined inclusion criteria for
being included into final analysis. 20/21 controls asked for a
second capnography for assessment of short term reproducibility
of the KPIv produced two technically acceptable tests. 68/87
patients with CF and 38/38 controls performed technically
acceptable MBW measurements for assessment of LCI.
Mean age (range) was 12.1 (4.3–24.6) years in patients with
CF and 11.9 (5.3–20.3) years in controls; age did not differ
between patients and controls (p=0.761). Mean weight (range)
was 38.2 (16.9–66.2) kg in patients with CF and 41.5 (16.3–
79.0) kg in controls; weight did not differ between the groups
(p=0.250). Mean height (range) was 144.0 (104.3–183) cm in
patients with CF and 148.5 (108.5–184.1) cm in controls;
height did not differ between the groups (p=0.255).
The calculated parameters did not differ between the two
study centres.
The parameters calculated from capnography and MBW in
patients with CF and controls are listed in Table 1. The upper
limit of normal for the KPIv was 9.3. S2, S3 and KPIv were
normally distributed.
Tidal volume per kilogram body weight did not differ
between patients with CF and healthy subjects. S3, KPIv
and LCI were significantly higher in patients with CF when
compared to controls; S2 did not differ between the groups.
There was no correlation between tidal volume per kilogrambody weight and S3, KPIv or LCI, neither in patients with CF
nor in controls. S3 and KPIv did correlate with absolute tidal
volumes.
However, there was an overlap of individual KPIv results
between patients and controls (Fig. 2).
The LCI correlated significantly with the KPIv (r=0.610;
p=b0.001) (Fig. 3), S2 (r=−0.198; p=b0.042) and S3 (r=0.376;
p=b0.001).
While differences of S2, S3, KPIv and LCI between repeated
tests were not significant (Table 2) limits of agreement for the
KPIv were wide (Fig. 4).
4. Discussion
Capnography based on expiratorymolar mass–volume-curves
derived from an ultrasonic flow sensor is feasible in children
and adolescents with CF and healthy controls of the same age
range. Overall success rate was 90.6% and did not differ between
patients and controls.
42
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Fig. 4. Short term reproducibility of the capnographic index (KPIv=[S3/S2]∗100)
in controls (n=20/21): mean KPIv of the 1st and the 2nd tests is plotted for each
individual against the individual difference between the two tests. The solid line
represents themean difference between the two tests for the group; the broken lines
cover two standard deviations above and below this mean difference.
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Fig. 3. Individual capnographic index (KPIv=[S3/S2]∗100) versus lung clearance
index (LCI=cumulative expired volume/functional residual capacity) in n=68/87
CF patients (●) vs. 38/38 controls (○). Vertical line: upper limit of normal of LCI
(=7.0). Horizontal line: upper limit of normal of KPIv (=9.3).
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lated parameters reflect to some extent ventilation inhomoge-
neity as a marker of peripheral airway obstruction in CF lung
disease.
S3 and KPIv differed significantly between the two groups.
There was a significant correlation between KPIv and LCI
as the reference parameter for reflecting over all ventilation
inhomogeneity. Short term reproducibility of KPIv did not
reveal a systematic difference but demonstrated wide limits of
agreement on an individual basis.
LCI results in patients with CF and healthy controls were
comparable to previous studies [5,8,23].
However, on an individual basis, there was a relevant overlap
for KPIv and S3 between patients with CF and controls. This was
more apparent in subjects breathing with lower tidal volumes
per kg body weight. It was the study aim to develop a simple
screening tool including simple test procedures. Therefore, the
present data were obtained without any automated control of tidalTable 2
Short term reproducibility of parameters derived from the 1st and the 2nd
capnography and multiple breath washout is reported as mean of the group (SD) in
20 controls. Slope 2 of the CO2-expirogram = S2, slope 3 of the CO2-expirogram =
S3, capnographic index = KPIv ([S3/S2]∗100), mean tidal volume per kilogram
body weight = TV/kg, and Lung Clearance Index = LCI (cumulative expired
volume/functional residual capacity).
1st test 2nd test Mean difference p-value 95% C.I.
S2 [g/mol/L] 32.9 (8.2) 32.7 (8.3) 0.20 0.820 −1.57; 1.96
S3 [g/mol/L] 1.6 (0.7) 1.6 (0.6) −0.01 0.960 −0.25; 0.24
KPIv 4.8 (1.8) 4.9 (1.4) −0.10 0.773 −0.78; 0.59
TV/kg [mL] 12.8 (3.7) 12.3 (2.5) 0.50 0.361 −0.62; 1.62
LCI 6.1 (0.3) 6.3 (0.4) −0.14 0.207 −0.37; 0.09volume and breathing frequency. Consequently, several factors
may contribute to this overlap:
1) It may be that rebreathing of CO2 from the apparatus dead
space has occurred in younger participants with lower
absolute tidal volumes. Furthermore increased CO2 concen-
trations have been detected after expiration with an external
CO2-sensor in approximately 40–50 cm radius around the
equipment (personal observation). The increased CO2 was
still present at the start of the next inspiration. Such
rebreathing of CO2 even at low absolute concentration may
result in a falsely steep S2, with subsequent underestimation
of KPIv.
2) Prolonged expirations with end-expiratory breath holding
before the next inspiration cause underestimation of S3
resulting in underestimation of KPIv too.
3) Premature termination of expiration and early inspiration
has been observed relatively frequently during the measure-
ments, particularly in healthy controls. Such a breathing
pattern may occur in single breaths only or during the entire
test and is related to an increased breathing frequency. In
case of an incomplete expiration S3 and consecutively KPIv
are overestimated.
4) Current calculation of S3 is based on the endpoint of the
expirogram even if a clear alveolar plateau has not been
reached yet.
Defining a lower cut-off for tidal volumes of 8 mL/kg body
weight clearly improved selection of breaths with a suitable
plateau. However, it would be better to improve data collection
rather than subsequent exclusion of unacceptable breaths.
Therefore, implementation of an age adapted, weight related
and tidal volume and breathing frequency triggered incentive
may be a useful tool to further improve test quality and thus,
discrimination between health and disease.
282 S.I. Fuchs et al. / Journal of Cystic Fibrosis 12 (2013) 277–283Although a variability of almost 20% can be expected for
tidal breathing tests, short term reproducibility of S3 and KPIv
was considerably worse than known for the LCI [23]. Paired
t-tests indicated no statistical differences between subsequent
measurement occasions but limits of agreement were wide. It is
likely that reproducibility of parameters derived from capno-
graphy will improve once the aspects discussed above are taken
care of.
Breath by breath inspection of individual molar mass–
volume-curves in patients with diagnosed lung disease and
healthy controls demonstrates clear differences between the
traces (Fig. 1). Molar mass–volume-curves obviously contain
information about delayed CO2 exhalation from the alveolar
region and therefore reflect inhomogeneous ventilation. How-
ever, automated extraction of this information remains a
challenge. Implementation of an age adapted incentive,
optimised breath detection and selection and further reduction
of the apparatus dead space to prevent relevant rebreathing
of CO2 appear important. One cannot expect a simple tidal
breathing test without the use of an additional tracer gas to be
as accurate as a parameter derived from more sophisticated
measurements such as MBW. The intention of such a tidal
breathing test would therefore be to supplement rather than to
replace currently available methods.
Generating molar mass–volume-curves from flow and molar
mass signals derived from a handheld ultrasonic flow sensor
follows the known principles of conventional volumetric
capnography. However, the ultrasonic flow sensor avoids
limitations previously related to conventional capnography,
such as slow response time of gas analysers, need of calibration
procedures and difficulties in time delay correction of side
stream signals [25]. Problems related to separate CO2 analysers
as reported from older studies on capnography are therefore
not applicable. A current study on volumetric capnography in
asthmatic children and adolescents demonstrated the presence
of ventilation inhomogeneity that was reflected by an increased
S3 when compared to healthy controls. However, as individual
results have not been reported in this study, it remains unclear
whether there was an overlap between S3 results of healthy
controls and asthmatic patients too [26].
While conventional capnography has mainly been used in
ICU settings [27,28] the current approach is being developed
to screen for peripheral obstructive lung changes that may be
present in a number of chronic respiratory diseases. However, the
fact that capnography requires room air only will allow more
widespread use than possible for other gas dilution techniques
such as multiple or single breath washout that requires additional
(inert) gas supply. A recent study reported the use of double
inert tracer gas for assessing ventilation inhomogeneity during
tidal breathing. While discrimination between health and disease
was slightly better in this study compared with our data, there
was still considerable overlap [29].
In summary, capnography based on molar mass–volume
curves as a quick and simple tidal breathing test is feasible
from preschool age using an ultrasonic flow sensor equipment.
KPIv in patients with CF is different from control subjects
and correlates with the LCI. The method has the potential tobe introduced as a screening tool into clinical routine but
requires further adaptation and evaluation based on the present
experiences. Particularly, discrimination between patients and
controls on an individual basis should be improved before this
technique can be recommended for monitoring CF lung disease
and for assessing the response to therapeutic interventions.
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